{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:37:44Z","timestamp":1759412264582},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Norwegian Institute of Public Health","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1581-4","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T11:25:35Z","timestamp":1465298735000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Varicella-zoster virus susceptibility and primary healthcare consultations in Norway"],"prefix":"10.1186","volume":"16","author":[{"given":"Grazina","family":"Rimseliene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti","family":"Vainio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa","family":"Gibory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Valcarcel","family":"Salamanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmira","family":"Flem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"issue":"9544","key":"1581_CR1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365\u201376.","journal-title":"Lancet"},{"key":"1581_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","volume":"7","author":"P Bonanni","year":"2009","unstructured":"Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rumke H, Sadzot-Delvaux C, Senterre J, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7:26.","journal-title":"BMC Med"},{"key":"1581_CR3","first-page":"17","volume":"123","author":"AA Gershon","year":"2012","unstructured":"Gershon AA, Chen J, Davis L, Krinsky C, Cowles R, Reichard R, Gershon M. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc. 2012;123:17\u201333.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"1581_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0065-3527(08)60074-3","volume":"46","author":"AM Arvin","year":"1996","unstructured":"Arvin AM, Moffat JF, Redman R. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv Virus Res. 1996;46:263\u2013309.","journal-title":"Adv Virus Res"},{"issue":"3 Suppl","key":"1581_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.30","volume":"9","author":"RW Johnson","year":"2010","unstructured":"Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9(3 Suppl):21\u20136.","journal-title":"Expert Rev Vaccines"},{"issue":"9925","key":"1581_CR6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","volume":"383","author":"R Prymula","year":"2014","unstructured":"Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, Stefkovicova M, Usonis V, Wysocki J, Douha M, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383(9925):1313\u201324.","journal-title":"Lancet"},{"key":"1581_CR7","unstructured":"European Medicines Agency, EMEA: Zostavax. European Public Assessment Report. Summary of product characteristics. 2009. www.emea.europa.eu . Accessed 22 May 2013."},{"issue":"22","key":"1581_CR8","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, et al. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. N Engl J Med. 2015;372(22):2087\u201396.","journal-title":"N Engl J Med"},{"issue":"32","key":"1581_CR9","first-page":"241","volume":"73","author":"WHO","year":"1998","unstructured":"WHO. Varicella vaccines. WHO position paper. Wkly Epidemiol Rec. 1998;73(32):241\u20138.","journal-title":"Wkly Epidemiol Rec"},{"issue":"25","key":"1581_CR10","first-page":"265","volume":"89","author":"WHO","year":"2014","unstructured":"WHO. Varicella and herpes zoster vaccines: WHO position paper. Wkly Epidemiol Rec. 2014;89(25):265\u201387.","journal-title":"Wkly Epidemiol Rec"},{"issue":"5","key":"1581_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.inf.0000122606.88429.8f","volume":"23","author":"B Rentier","year":"2004","unstructured":"Rentier B, Gershon AA. European Working Group on V. Consensus: varicella vaccination of healthy children--a challenge for Europe. Pediatr Infect Dis J. 2004;23(5):379\u201389.","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 5","key":"1581_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/1469-0691.12580","volume":"20","author":"P Carrillo-Santisteve","year":"2014","unstructured":"Carrillo-Santisteve P, Lopalco PL. Varicella vaccination: a laboured take-off. Clin Microbiol Infect. 2014;20 Suppl 5:86\u201391.","journal-title":"Clin Microbiol Infect"},{"key":"1581_CR13","unstructured":"The European Centre for Disease Prevention and Control. Vaccine Schedule. http:\/\/vaccine-schedule.ecdc.europa.eu\/pages\/scheduler.aspx . Accessed 06 Oct 2014."},{"issue":"6","key":"1581_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066485","volume":"8","author":"B Ogunjimi","year":"2013","unstructured":"Ogunjimi B, Van Damme P, Beutels P. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review. PLoS One. 2013;8(6), e66485.","journal-title":"PLoS One"},{"key":"1581_CR15","unstructured":"Norwegian Institute of Public Health. Varicella and herpes zoster vaccination (2014). http:\/\/www.fhi.no\/eway\/default.aspx?pid=239&trg=Content_6493&Main_6157=6287:0:25,5501&MainContent_6287=6493:0:25,6826&Content_6493=6441:68714::0:6446:26:::0:0 . Accessed 26 March 2015."},{"key":"1581_CR16","unstructured":"Ministry of Health and Care Services of Norway. Reimbursement Prescription Regulations (Bl\u00e5resept-forskriften). 2007. https:\/\/lovdata.no\/dokument\/SF\/forskrift\/2007-06-28-814 . Accessed 05 Aug 2015."},{"key":"1581_CR17","unstructured":"Norwegian Medicines Agency. Varilrix. http:\/\/www.legemiddelverket.no\/Legemiddelsoek\/Sider\/Legemiddelvisning.aspx?pakningId=0a170bc8-797f-4503-8377-941c07736cca&searchquery=varilrix&f=Han;MtI;Vir;ATC;Var;Mar;Mid;Avr&pane=0 . Accessed 22 Apr 2015."},{"issue":"5","key":"1581_CR18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2796.2011.02474.x","volume":"271","author":"HF Tseng","year":"2012","unstructured":"Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, Baggs J, Weinmann S, Baxter R, Nordin J, et al. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012;271(5):510\u201320.","journal-title":"J Intern Med"},{"issue":"3","key":"1581_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365548.2012.719634","volume":"45","author":"E Quist-Paulsen","year":"2013","unstructured":"Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V. Infectious encephalitis: a description of a Norwegian cohort. Scand J Infect Dis. 2013;45(3):179\u201385.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"1581_CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jnnp.64.4.539","volume":"64","author":"KM Myhr","year":"1998","unstructured":"Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Gronning M, Kalvenes MB, Nyland H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case\u2013control study from western Norway. J Neurol Neurosurg Psychiatry. 1998;64(4):539\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1581_CR21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1403494811399653","volume":"39","author":"SE Bjerke","year":"2011","unstructured":"Bjerke SE, Vangen S, Holter E, Stray-Pedersen B. Infectious immune status in an obstetric population of Pakistani immigrants in Norway. Scand J Public Health. 2011;39(5):464\u201370.","journal-title":"Scand J Public Health"},{"key":"1581_CR22","unstructured":"Statistics Norway. Population statistics. http:\/\/www.ssb.no\/befolkning . Accessed 26 Mar 2015."},{"issue":"16","key":"1581_CR23","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.vaccine.2006.01.026","volume":"24","author":"U Heininger","year":"2006","unstructured":"Heininger U, Desgrandchamps D, Schaad UB. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16\u00a0months of age. Vaccine. 2006;24(16):3258\u201360.","journal-title":"Vaccine"},{"issue":"9","key":"1581_CR24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/CVI.00348-06","volume":"14","author":"M Koskiniemi","year":"2007","unstructured":"Koskiniemi M, Lappalainen M, Schmid DS, Rubtcova E, Loparev VN. Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland. Clin Vaccine Immunol. 2007;14(9):1057\u201361.","journal-title":"Clin Vaccine Immunol"},{"key":"1581_CR25","unstructured":"Norwegian Institute of Public Health. Fruktbarhet, f\u00f8dealder og helse - faktaark med statistikk. 2015. http:\/\/www.fhi.no\/artikler\/?id=67742 . Accessed 8 May 2015."},{"key":"1581_CR26","unstructured":"The Norwegian Directorate for Education and Training. Norske barnehager i tall. 2013. http:\/\/www.udir.no\/Upload\/barnehage\/Forskning_og_statistikk\/Statistikk\/US2013_barnehager.pdf?epslanguage=no . Accessed 17 Oct 2014."},{"issue":"45","key":"1581_CR27","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866\u201372.","journal-title":"Vaccine"},{"issue":"2","key":"1581_CR28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcv.2006.07.012","volume":"37","author":"A Svahn","year":"2006","unstructured":"Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, Linde A. Changes in seroprevalence to four herpesviruses over 30\u00a0years in Swedish children aged 9\u201312 years. J Clin Virol. 2006;37(2):118\u201323.","journal-title":"J Clin Virol"},{"issue":"4","key":"1581_CR29","first-page":"495","volume":"63","author":"J Siennicka","year":"2009","unstructured":"Siennicka J, Trzcinska A, Rosinska M, Litwinska B. Seroprevalence of varicella-zoster virus in Polish population. Przegl Epidemiol. 2009;63(4):495\u20139.","journal-title":"Przegl Epidemiol"},{"issue":"44","key":"1581_CR30","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2013.08.029","volume":"31","author":"A Lier van","year":"2013","unstructured":"van Lier A, Smits G, Mollema L, Waaijenborg S, Berbers G, van der Klis F, Boot H, Wallinga J, de Melker H. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013;31(44):5127\u201333.","journal-title":"Vaccine"},{"issue":"4","key":"1581_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.dr.2013.08.003","volume":"33","author":"MH Bornstein","year":"2013","unstructured":"Bornstein MH, Jager J, Putnick DL. Sampling in Developmental Science: Situations, Shortcomings, Solutions, and Standards. Dev Rev. 2013;33(4):357\u201370.","journal-title":"Dev Rev"},{"issue":"25\u201326","key":"1581_CR32","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/S0264-410X(02)00255-4","volume":"20","author":"H Kelly","year":"2002","unstructured":"Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccin. 2002;20(25\u201326):3130\u20136.","journal-title":"Vaccin"},{"issue":"1","key":"1581_CR33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","volume":"208","author":"S Waaijenborg","year":"2013","unstructured":"Waaijenborg S, Hahne SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, de Melker HE, Wallinga J. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10\u20136.","journal-title":"J Infect Dis"},{"issue":"21","key":"1581_CR34","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","volume":"33","author":"IG Helmuth","year":"2015","unstructured":"Helmuth IG, Poulsen A, Suppli CH, Molbak K. Varicella in Europe-A review of the epidemiology and experience with vaccination. Vaccine. 2015;33(21):2406\u201313.","journal-title":"Vaccine"},{"issue":"4","key":"1581_CR35","first-page":"646","volume":"31","author":"DS Akram","year":"2000","unstructured":"Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, Rehman Nu, Olowokure B, Weil J, Bock H, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health. 2000;31(4):646\u20139.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"1581_CR36","unstructured":"Statistics Sweden. Sveriges framtida befolkning 2015\u20132060. 2015. http:\/\/www.scb.se\/Statistik\/_Publikationer\/BE0401_2015I60_BR_BE51BR1502.pdf . Accessed 12 May 2015."},{"key":"1581_CR37","unstructured":"The Ministry of the Interior of Finland. Annual report on immigration. 2009, 2012. http:\/\/www.migri.fi\/download\/46518_46515_Maahanmuuton_tilastokatsaus_2012_ENG_web.pdf?e251abcb8449d288 . Accessed 12 May 2015."},{"key":"1581_CR38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-12-140","volume":"12","author":"GG Rijckevorsel van","year":"2012","unstructured":"van Rijckevorsel GG, Damen M, Sonder GJ, van der Loeff MF, van den Hoek A. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infect Dis. 2012;12:140.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1581_CR39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","volume":"127","author":"M Brisson","year":"2001","unstructured":"Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos L, De Serres G. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127(2):305\u201314.","journal-title":"Epidemiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1581-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:53:20Z","timestamp":1498319600000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1581-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1581-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]},"article-number":"254"}}